Abstract
End stage renal disease (ESRD) patients suffer from advanced renal diseases and actually nonfunctioning kidneys, and need kidney transplantation or dialysis. Hemodialysis (HD) is the most used method and requires a vascular access (VA). Arteriovenous fistula (AVF) is the first choice of VA over the world for having least morbidity and mortality. Despite the wide-spread use of AVFs, the rate of AVF failures are notable. Detecting the factors that cause AVF failure can reduce repeating VA surgeries and hospitalization of ESRD patients. Present research studies 480 Iranian HD patients who underwent AVF surgery from 2010 to 2017 and aged 18–90 years old, using data mining techniques. (i) The AVF failure rate was equal to 8.96%, such that AVF failure has occurred in 3.54% and 5.52% of HD patient with and without hypertension, respectively. (ii) The rate of non-failure AVF in hypertensive patients is 61.46%, whereas the same rate for patients with negative history of hypertension reaches to 29.58%. (iii) Hypertension has a significant inverse association with AVF failure (Spearman’s ρ = −0.160, P-value ≤ 0.005). (iv) The decision tree (with accuracy rate = 92.24%) shows less AVF failure in hypertsensive patients (5.53%) comparing with non-hypertensive patients (15.09%). (v) The AVFs with greater failure rates and non-hypertensive HD patients were clustered together. “Significantly lower risk of AVF failure was associated with presence of a positive history of hypertension; in other words, positive history of hypertension has an adverse effect on AVF failure and Hypertensive HD patients have more maturated AVF.”
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Stellate ganglion block for preserving arteriovenous fistula in hemodialysis patients undergoing major lower limb orthopedic surgeries: randomized control trial
BMC Anesthesiology Open Access 31 May 2025
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout





References
Kim JU, Kim M, Kim S, Nguyen TT, Kim E, Lee S, et al. Dendritic cell dysfunction in patients with end-stage renal disease. Immune Netw. 2017;17:152–62.
Mihajlovic M, Heuvel LP, Hoenderop JG, Jansen J, Wilmer MJ, Westheim AJF, et al. Allostimulatory capacity of conditionally immortalized proximal tubule cell lines for bioartificial kidney application. Nat Sci Rep. 2017;7:7103.
Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet. 2017;389:1238–52.
Borzou SR, Mahdipour F, Oshvandi K, Salavati M, Alimohammadi N. Effect of mealtime during hemodialysis on patients’ complications. J Caring Sci. 2016;5:277–86.
Mitra S, Mitsides N. Technical aspects of hemodialysis. In: Magee CC, Tucker JK, Singh AK, editors. Core concepts in dialysis and continuous therapies. 2nd Vol. New York, NY:Springer New York LLC. 2016, pp. 15–26..
Santoro D, Benedetto F, Mondello P, Pipitò N, Barillà D, Spinelli F, et al. Vascular access for hemodialysis: current perspectives. Dovepress Int J Nephrol Renov Dis. 2014;7:281–94.
Stolic R. Most important chronic complications of arteriovenous fistulas for hemodialysis. Med Princ Pract. 2013;22:220–8.
Khavanin Zadeh M, Gholipour F, Naderpour Z, Porfakharan M. Relationship between vessel diameter and time to maturation of arteriovenous fistula for hemodialysis access. Int J Nephrol. 2011;2012:942950.
Vazquez MA. Vascular access for dialysis: recent lessons and new insights. Curr Opin Nephrol Hypertens. 2009;18:116–21.
Feldman HI, Kobrin S, Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol. 1996;7:523–35.
Roy-Chaudhury P, Kelly BS, Zhang J, Narayana A, Desai P, Melhem M, et al. Hemodialysis vascular access dysfunction: from pathophysiology to novel therapies. Blood Purif. 2003;21:99–110.
Zarjou A, Agarwal A. Superoxide in AVF dysfunction: a new target for intervention. Am J Physiol Ren Physiol. 2012;303:F1599–F1600.
Rezapour M, Taran S, Parast MB, Zadeh MK. The impact of vascular diameter ratio on hemodialysis maturation time: evidence from data mining approaches and thermodynamics law. Med J Islam Repub Iran. 2016;30:359 www.ncbi.nlm.nih.gov/pmc/articles/PMC4934486/
Sepehri MM., Khavaninzadeh M., Rezapour M and Teimourpour, B. A data mining approach to fistula surgery failure analysis in hemodialysis patients. Proceedings of 2011 18th Iranian Conference of Biomedical Engineering (ICBME). Tehran, Iran: IEEE. 2011; pp. 21–26.
Rezapour M, Khavanin Zadeh M, and Sepehri MM (2013). Implementation of predictive data mining techniques for identifying risk factors of early AVF failure in hemodialysis patients. Comput Math Meth Med. 2013; 2013:830745 https://doi.org/10.1155/2013/830745
Rezapour M, Khavanin Zadeh M. Association between non-matured arteriovenus fistula and blood pressure in hemodialysis patients. Med J Islam Repub Iran. 2014;28:144 http://www.ncbi.nlm.nih.gov/pubmed/25695002
Khavanin Zadeh M, Rezapour M, Sepehri MM. Data mining performance in identifying the risk factors of early arteriovenous fistula failure in hemodialysis patients. Int J Hosp Res. 2013;2:49–54. http://ijhr.iums.ac.ir/index.php/ijhr/article/view/52/116
Khavanin ZM, Gholipour F, Hadipour R. The effect of hemoglobin level on arteriovenous fistula survival in Iranian hemodialysis patients. J Vasc Access. 2008;9:133–6.
Rezapour M, Payani E, Taran M, Rajabzadeh Ghatari A, Khavanin Zadeh M. Roles of triglyceride and phosphate in atherosclerosis of diabetic hemodialysis patients. Med J Islam Repub Iran. 2017;31:465–71.
Valerianova A, Kudlicka J, Chytilova E, Grauova B, Krupickova Z, Malik J. Factors influencing dialysis arteriovenous graft survival. J Vasc Access. 2017;18:139.
Duque JC, Tabbara M, Martinez L, Cardona J, Vazquez-Padron RI, Salman LH. Dialysis arteriovenous fistula failure and angioplasty: intimal hyperplasia and other causes of access failure. Am J Kidney Dis. 2017;69:147–51.
MacRae JM, Dipchand C, Oliver M, Moist L, Lok C, Clark E, et al. Arteriovenous access failure, stenosis, and thrombosis. Can J Kidney Health Dis. 2016;3:2054358116669126.
Salimi F, Shahabi S, Talebzadeh H, Keshavarzian A, Pourfakharan M, Safaei M. Evaluation of diagnostic values of clinical assessment in determining the maturation of arteriovenous fistulas for satisfactory hemodialysis. Adv Biomed Res. 2017;6:18.
Yoo DW, Yoon M, Jun HJ. Successful access rate and risk factor of vascular access surgery in arm for dialysis. Vasc Spec Int. 2014;30:33.
Miller PE, Tolwani A, Luscy CP, Deierhoi MH, Bailey R, Redden DT, et al. Predictors of adequacy of arteriovenous fistulas in hemodialysis patients. Kidney Int. 1999;56:275–280.
Tordoir JH, Rooyens P, Dammers R, van der Sande FM, de Haan M, Yo TI. Prospective evaluation of failure modes in autogenous radiocephalic wrist access for haemodialysis. Nephrol Dial Transplant. 2003;18:378–383.
Rezapour M, Sepehri MM, Khavanin Zadeh M, Alborzi M, (2018). A new method to determine anastomosis angle configuration for arteriovenous fistula maturation. Med J Islam Repub Iran (in press).
Su X, Hu J, Huang S, Ning K. Rapid comparison and correlation analysis among massive number of microbial community samples based on MDV data model. Sci Rep. 2014;4:6393.
Sari F, Taşkapan H, Sığırcı A, Akpınar B. Evaluation of risk factors for arteriovenous fistula failure in patients undergoing hemodialysis. Erciyes Med J. 2016;38:12–9.
Fitzgerald JT, c A, Chin AI, McVicar JP, Perez RV, Troppmann C. Outcomes of upper arm arteriovenous fistulas for maintenance hemodialysis access. Arch Surg. 2004;139:201–8.
Brimble KS, Rabbat CG, Schiff D, Ingram AJ. The clinical utility of Doppler ultrasound prior to arteriovenous fistula creation. Semin Dial. 2001;14:314–7.
Wong V, Ward R, Taylor J, Selvakumar S, How TV, Bakran A. Factors associated with early failure of arteriovenous fistulae for haemodialysis access. Eur J Vasc Endovasc Surg. 1996;12:207–213.
Parmar J, Aslam M, Standfield N. Pre-operative radial arterial diameter predicts early failure of arteriovenous fistula (AVF) for haemodialysis. Eur J Vasc Endovasc Surg. 2007;33:113–115.
Silva MB Jr, Hobson RW II, Pappas PJ, Jamil Z, Araki CT, Goldberg MC, et al. A strategy for increasing use of autogenous hemodialysis access procedures: impact of preoperative noninvasive evaluation. J Vasc Surg. 1998;27:302–308.
Mendes RR, Farber MA, Marston WA, Dinwiddie LC, Keagy BA, Burnham SJ. Prediction of wrist arteriovenous fistula maturation with preoperative vein mapping with ultrasonography. J Vasc Surg. 2002;36:460–463.
Huber TS, Ozaki CK, Flynn TC, Lee WA, Berceli SA, Hirneise CM, et al. Prospective validation of an algorithm to maximize native arteriovenous fistulae for chronic hemodialysis access. J Vasc Surg. 2002;36:452–459.
Seeger JM, Schmidt JH, Flynn TC. Preoperative saphenous and cephalic vein mapping as an adjunct to reconstructive arterial surgery. Ann Surg. 1987;205:733.
Iwatsuki K, Cardinale GJ, Spector S, Udenfriend S. Hypertension: increase of collagen biosynthesis in arteries but not in veins. Science. 1977;198:403–405.
Jalil JE, Doering CW, Janicki JS, Pick R, Shroff SG, Weber KT. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res. 1989;64:1041–1050.
Nadar SK, Blann AD, Kamath S, Beevers DG, Lip GY. Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol. 2004;44:415–422.
Tayebjee MH, Nadar S, Blann AD, Beevers DG, MacFadyen RJ, Lip GY. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Am J Hypertens. 2004;17:764–769.
Monroy-Cuadros M, Yilmaz S, Salazar-Bañuelos A, Doig C. Risk factors associated with patency loss of hemodialysis vascular access within 6 months. Clin J Am Soc Nephrol. 2010;5:1787–92.
Acknowledgements
This article is based on part of results extracted from Ph.D. thesis recently defended by the first author (Dr. Mohammad Rezapour) at the Department of Information Technology Management, Science and Research Branch, Islamic Azad University, Tehran, Iran, supervised by Prof. Dr. Mohammad Mehdi Sepehri and Dr. Morteza Khavanin Zadeh (MD) and advisory of Dr. Mahmood Alborzi.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Rezapour, M., Khavanin Zadeh, M., Sepehri, M.M. et al. Less primary fistula failure in hypertensive patients. J Hum Hypertens 32, 311–318 (2018). https://doi.org/10.1038/s41371-018-0052-3
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41371-018-0052-3